🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study aims to assess the safety and efficacy of Viaskin Peanut to induc...
Status
Completed
Location
University of Arizona Health Science
Start Date
2017-07-31
Trial ID
NCT03211247
A study to investigate the safety and tolerability of both single and multi...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-03-12
Trial ID
NCT00459550
Treatments Being Tested
AZD6553 is a new drug being developed as a possible treatment for patients ...
Status
Terminated
Location
Research Site
Start Date
2010-02
Trial ID
NCT01068184
This study is being performed to comply with regulatory requirements that a...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-17
Trial ID
NCT02293148
The primary objective of this study is to evaluate the safety, tolerability...
Status
Completed
Location
ICON Development Solutions
Start Date
2014-07
Trial ID
NCT02211625
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety, tolerability, im...
Status
Recruiting
Location
AusperBio Investigational Site
Start Date
2026-04-13
Trial ID
NCT07511218
Treatments Being Tested
This study is a two-part trial consisting of Part A (presented in this reco...
Status
Completed
Location
Alta Bates Summit Medical Center
Start Date
2012-09-18
Trial ID
NCT01628393
The purpose of this study is to assess the safety and tolerability of JNJ-5...
Status
Completed
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02609789
Treatments Being Tested
The main purpose of this study is to evaluate the safety and tolerability o...
Status
Terminated
Location
Parexel Early Phase Unit at Glendale
Start Date
2022-08-11
Trial ID
NCT05486208
The present phase 1b/2 randomised, double-blind, placebo-controlled, two-pa...
Status
Recruiting
Location
University Hospital Düsseldorf
Start Date
2023-04-14
Trial ID
NCT07304843
Treatments Being Tested